目的：分析16例食管癌贲门癌伴门脉高压症的围术期处理及外科治疗体会。
Objective: To evaluate the surgical treatment of esophageal or cardiac carcinoma with portal hypertension in 16 patients.
MRI可辨别肺癌放疗后纤维化抑或肿瘤复发，区分肺门癌块与阻塞性肺不张；
MRI could distinguish porstradiotherapy lung fibroid masses from carcinoma recurrence and pulmonary neoplasm from obstructive atelectasis.
肺鳞状细胞癌由肺门向胸膜扩散的又一例子。
This is another squamous cell carcinoma that extends from hilum to pleura.
目的建立人肝门部胆管癌裸鼠瘤株模型。
Objective To establish a xenografted model of human hilar cholangiocarcinoma in nude mice.
方法将人肝门部胆管癌标本进行细胞培养，传代。
Methods The fresh human hilar cholangiocarcinoma specimen was cultured.
目的：探讨影响肝门部胆管癌术后严重并发症发生的危险因素。
Objective: to investigate the risk factors which influenced the serious postoperative complication of hilar cholangiocarcinoma.
目的介绍肝门部胆管癌的治疗进展动态。
Objective To introduce the development of therapy of hilar cholangiocarcinoma.
目的提高肝门部胆管癌手术治疗的效果。
Objectives To improve effect of the resection of hilar cholangiocarcinoma.
目的：探讨肝门区胆管癌的螺旋CT诊断、分类和选择不同CT检查技术的诊断价值。
Objective: To assess the spiral ct diagnosis, classification of hilar cholangiocarcinoma and the diagnostic advantage with different ct technical parameters.
癌组织中VEGF-C的表达与门静脉癌栓、肝门淋巴结转移和复发有关（P<0.05）。
The expression of VEGF-C was correlated with portal vein-emboli, lymph node metastasis and recurrence(P<0.05).
目的探讨通过超声引导经皮肝穿途径向门脉内放置内支架治疗癌栓引起的门静脉高压的效果。
Objective To evaluate the treatment of portal hypertension caused by tumor thrombi with percutaneous transhepatic portal vein stent implantation under the US guidance.
结果p53、CD34在肝癌组织的表达比非癌组明显增高，且在肝癌组中伴有与不伴门脉瘤栓的两组间有统计学差别（P<0.05）。
Results The expression of P53, CD34was higher in the HCC group than in the inner group, and their expression was associated with portal vein embolus(P<0.05).
再次谢谢马哥！PLC可由血道转移，随后是间质浸润、淋巴道转移，或如此例直接由肺门或纵隔淋巴结的转移癌蔓延而来。
PLC results from hematogenous spread to lung, with subsequent interstitial and lymphatic invasion, or, as in this case, direct lymphatic spread of tumor from hilar or mediastinal lymph nodes.
目的总结作者应用肝部分切除联合肝十二指肠骨髂化治疗肝门部胆管癌的临床经验。
Objective to summarize the surgical experience of partial hepatectomy with skeletonization of the hepatoduodenal ligament in the treatment of hilar cholangiocarcinoma.
目的提高肝门部胆管癌的诊断水平。
Objective To improve diagnosis of hilar cholangiocarcinoma (HCCA).
结果治疗有效率有意义的影响因素为治疗方法、肿块类型、肿瘤血供、肝功能、门脉癌栓、碘化油沉积。
Results The factors likely to affect the curative effectiveness were the way of treatment, tumor type, blood supply of the tumor, liver function, portal cancerous thrombus and lipiodol deposit.
方法回顾分析22例经手术和病理证实的肝门部胆管癌患者的MRI及MRCP表现，以了解其影像特征和肿瘤的组织病理学特点。
Methods MRI and MRCP imaging as well as histopathologic features of 22 patients with hilar cholangiocarcinoma with surgical and pathological proofs were analyzed and studied retrospectively.
目的：探讨经皮肝穿刺胆道造影术（PTC）在肝门胆管癌分型诊断中的作用。
Objective: To study the value of percutaneous transhepatic cholangiography(PTC) in typical diagnosis of hepatic hilar cholangiocarcinoma.
目的探讨单通道双支架植入技术治疗肝门部胆管癌的可行性和临床应用价值。
Objective To evaluate the feasibility and clinical application of two stents insertion via single tract for treatment of hepatic hilar cholangiocarcinoma.
胆管内或肝门区肿块、肝脏直接侵犯征象诊断胆管癌的灵敏度为100%，阳性预测值分别为20%和25%。
The sensitivity of mass on or in biliary duct or hepatic hilar area and liver invading of tumors was 100% but the positive predictive value were 20% and 25%, respectively.
结论MRI和MRCP联合应用有助于肝门部胆管癌的诊断、分型及手术可切除性的评估。
Conclusion MRCP combined with MRI is very useful for diagnosis and classification of the hepatic hilar cholangiocarcinoma and assessment of tumor respectability.
目的探讨肝门部胆管癌术前改良T分期系统的临床应用价值。
Objective To discuss the applicable clinic value of proposed T-staging for hilar cholangiocarcinoma.
结果建立了肝门部胆管癌术后生存危险状态函数。
Results We have established mathematic function to evaluate postoperative survival risk state of hilar cholangiocarcinoma.
结论：螺旋CT门脉造影可较全面地显示门静脉癌栓情况。
Conclution: Helical CT portography (CTP) can provide the comprehensive information about the portal vein cancer embolus.
目的总结肝门部胆管癌扩大根治术中肝动脉重建的临床经验。
Objective To sum up the clinical experience of hepatic artery reconstruction during radical surgery for treatment of hilar cholangiocarcinoma.
《国际肝病》：不能手术切除的门胆管癌预后非常差，对于这些患者，您如何能使治疗达到最优？
Hepatology Digest: Unresectable Hilar cholangiocarcinoma carries a poor prognosis. How would you optimize therapeutic avenues for these patients?
目的评价超声对肝门部胆管癌术前分期诊断价值。
Purpose To evaluate staging of hilar cholangiocarcinoma by ultrasound.
目的评价超声对肝门部胆管癌术前分期诊断价值。
Purpose To evaluate staging of hilar cholangiocarcinoma by ultrasound.
应用推荐